1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Vistamedi Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models CYP2C19 Genotype-Guided Clopidogrel Treatment, CYP2C19 Genotype Guided Antiplatelet Treatment Alternative to Clopidogrel, The Conventional Clopidogrel Treatment - Coronary Artery Disease, Clopidogrel Resistance | Not applicable | Completed | Vistamedi Ltd. | 283 | 2023-06-15 | 2025-09-26 |
Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Coronary Thrombosis (1) · Death (1) · Hemorrhage (1)
Georgia (1)
Konstantine Liluashvili, MD., PH.D. (1) · Levan Jijeishvili, MD, MPH (1) · Tornike Batavani, MD, MPH (1)